This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Hee Jin Kim: Innovator in Antineoplastic Compounds
Introduction
Hee Jin Kim is a notable inventor based in Pusan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of camptothecin compounds. With a total of 2 patents, his work focuses on enhancing the efficacy of antineoplastic agents.
Latest Patents
His latest patents include innovative methods for preparing camptothecin derivatives and their pharmaceutically acceptable salts. These derivatives are modified in the B-ring and E-ring, resulting in improved water solubility and enhanced antineoplastic effects. Additionally, he has developed intermediates for the synthesis of these camptothecin derivatives, which are crucial for advancing cancer treatment.
Career Highlights
Hee Jin Kim is currently associated with Chong Kun Dang Corporation, a prominent player in the pharmaceutical industry. His research and inventions have positioned him as a key figure in the development of effective cancer therapies.
Collaborations
He has collaborated with notable coworkers, including Sang Sup Jew and Hee Soon Lee, who contribute to the innovative environment at Chong Kun Dang Corporation.
Conclusion
Hee Jin Kim's work in the field of antineoplastic compounds showcases his dedication to improving cancer treatment through innovative pharmaceutical solutions. His contributions are paving the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile